Skip to content

Acute Effects of Natural and Interesterified Fats-margarine on Lipemic and Insulinemic Response

Acute Effects of Natural and Interesterified Fats-formulated Margarine on Lipemic and Insulinemic Response

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02194673
Enrollment
20
Registered
2014-07-18
Start date
2012-01-31
Completion date
2012-12-31
Last updated
2014-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Interesterified (IE) fat blends will respond differently in terms of postprandial lipemia and insulinemic responses compare to a trans free palm margarine (TFPM).

Detailed description

The objective of this study was to investigate whether IE-fat blends behave differently on postprandial serum lipid, insulin, C-peptide and glucose concentration compare to TFPM. A randomised, double-blind crossover (3 × 3 arms) orthogonal Latin-square design was used and conducted on 10 males and 10 females adults. During postprandial challenge day, each subject received an a test muffin incorporated with test margarine. Blood samples were collected at half-hourly intervals until 4 hr by using cannulation technique.

Interventions

OTHERTrans free palm margarine

A randomised, double-blind crossover (3 × 3 arms) orthogonal Latin-square design was used and conducted on 10 males and 10 females adults.

OTHERInteresterified Palm based margarine

A randomised, double-blind crossover (3 × 3 arms) orthogonal Latin-square design was used and conducted on 10 males and 10 females adults.

OTHERIE Soybean oil-based margarine

A randomised, double-blind crossover (3 × 3 arms) orthogonal Latin-square design was used and conducted on 10 males and 10 females adults.

Sponsors

IMU University, Malaysia
CollaboratorOTHER
Universiti Putra Malaysia
CollaboratorOTHER
Malaysia Palm Oil Board
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Body Mass Index (BMI) between 18.5 and 24.9 * \<130mmHg for systolic pressure and \<80 mmHg for diastolic pressure * Blood glucose level in the range of 3.9 to 5.5 mmol/L * Total cholesterol less than 5.17 mmol/L * No use of tobacco and no consumption of alcohol.

Exclusion criteria

* Suffer from chronic disease * Metabolic syndrome * Consuming any medical prescriptions * People with blood clotting problem * Women who are pregnant * Hypertensive person

Design outcomes

Primary

MeasureTime frame
Change in serum triglycerides level of subjects as a measure of postprandial triglycerides responseBaseline, 4 hours

Secondary

MeasureTime frame
Change in the level of plasma insulin, c-peptide and serum glucose as a measure of postprandial insulinemic responseBaseline, 4 hours

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026